Other

Angel Medical Systems Inc.

The Johns Hopkins University

Neuropace, Inc.

Cathco, Inc.

Cordis Corporation

Isostent, Inc.

Ablative Solutions, Inc.

Fischell Innovations, LLC

Aseko, Inc.

Svelte Medical Systems, Inc.

United States of America, As Represented by the Secretary of the Navy

Arrow International Investment Corp.

C. R. Bard, Inc.

Parker-hannifin Corporation

Robert E Fischell

David R Fischell

Tim A Fischell

Jonathan Harwood

Steven R Johnson

Eric Thomas Johnson

Andy Edward Denison

Darrin James Kent

Robert Ryan Ragland

Jeff Alan Burke

Christopher Scott Hayden

Benjamin D Pless

Robert C Booth

Scott J S Fischell

Adrian R M Upton

Thomas K Tcheng

Stanley P Woods

Joseph P Fredrick

Adrian R Upton

David Christopher Majercak

Fernando DiCaprio

Janet Burpee

Susan R Fischell

Michael Sasha John

Robert Burgermeister

Bruce Hopenfeld

Nicholas A Green

William R Powell

Emily Ma

Dieter Stockel

Glen H Fountain

Dave Vondle

Mark L Pomeranz

Albert C Sadilek

William G Swift

Kuen Chang

Sean Salmon

Leopold Rolih

Michael Graves

Richard Barthel

Richard Boydston North

Hikmat Hojeibane

Stephen T Archer

Barbara Gibb

Chao C Chen

Arnold L Newman

Dennis Potts

Mark Zyzelewski

Richard L Harding

Robert I White, Jr

Philip B Fleck

I John Khan

Stephen T Kaye

Adrian Rm Upton

Donald A Todd

William A Easterbrook, Iii

Todd H Turnland

Charles M Blackburn

Victor Fei

Henry B Riblet

Peter C Lord

Priyanka Venkatesh

Qi Rui

Timothy J Lynch

Frederick F Mobley

Leigh Vinocur

Rachel Hyder

Rajesh Kalavalapally

Abirvab Deb

Tim E Fischell

Martha J Morell

Antonio Columbo

James J Thompson

Michael E Kopp

Scott Js Fischell

Scott Sj Fischell

An intravascular catheter for peri-vascular or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. A method can involve injection/infusion of the ablative fluid over an extended time period of at least 10 seconds or with two injections at two different penetration depths to reduce or eliminate patient pain during ablation.

Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures

An intravascular catheter for peri-vascular and/or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, and/or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The system may also include a means to limit and/or adjust the depth of penetration of the ablative fluid into and beyond the tissue of the vessel wall. The catheter may also include structures which provide radial and/or lateral support to the guide tubes so that the guide tubes expand uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

Peri-vascular tissue ablation catheter with support structures

An intravascular catheter for peri-vascular and/or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, and/or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The catheter may also include structures which provide radial and/or lateral support to the guide tubes so that the guide tubes expand uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

A blood coagulant assembly having a blood coagulant device adapted to be placed into a nostril of a patient suffering from a nose bleed. The blood coagulant device being initially placed within a blood coagulant device container which has a top section and a bottom section each secured to the other in a releasable manner. The blood coagulant device being mounted in a fixed position within the blood coagulant device container prior to removal of the blood coagulant device for insertion into a patient's nose that is bleeding. The blood coagulant device having a handle lower section and a handle upper section with a through opening passing through both the lower and upper handle sections. A blood coagulant material is secured onto an outer surface of the blood coagulant device to be placed against an inner surface of the nostril of a patient that is experiencing a bleeding nose for the purpose of stopping the nose from bleeding.

Means and method to stop bleeding from the nose

A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.

Means and method for improved glycemic control for diabetic patients

An integrated magnetic pulsation device for the treatment of foot pain that utilizes an electrical pulse generator and a magnetic coil situated within the same enclosure. The device having the capability to have a patient's foot placed onto the top of a magnetic coil or under that magnetic coil to expose that patient's foot to a series of high intensity magnetic pulsations. The device also including a control panel that directs a patient as to how to utilize the device for the treatment of that patient's foot pain.

Integrated magnetic pulsation device for the treatment of foot pain

An intravascular catheter for peri-vascular or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, such as nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The system may also control the depth of penetration of the ablative fluid into and beyond the tissue of the vessel wall. The catheter may also include structures which provide radial or lateral support to the guide tubes so that the guide tubes expand uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

An intravascular catheter for peri-vascular or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. A method can involve injection of the ablative fluid over an extended time period of at least 10 seconds or with two injections at two different penetration depths to reduce or eliminate patient pain during ablation.

A Transcranial Magnetic Stimulator (TMS) is used by a patient to treat a variety of human disorders including migraine headaches. The device has an electronic device to charge a capacitor to a high voltage which creates a high current in a magnetic coil which produces an intense magnetic pulse applied to the patient's head for treatment of migraine headaches or to other patient body parts to treat other disorders. The TMS may be reprogrammed remotely over the Internet to add additional pulses or additional time that the patient may use the TMS, during which time the TMS would continue to function. The data in the TMS may be sent over the Internet to the patient's physician and/or to a monitor to send the data to the company that manufactured the TMS.

Transcranial magnetic stimulation device for the treatment of migraine headaches

A transcranial magnetic stimulation device has a capacitor for storing electrical energy. A wire coil delivers a magnetic pulse when the capacitor is actuated to cause current flow through the wire coil. A charging circuit charges the capacitor and there is a sensor which includes an unactivated state and an activated state. A control circuit connected to the body sensor initiates the delivery of a magnetic pulse when current from the capacitor flows through the wire coil.

Transcranial magnetic stimulation device with body proximity sensors for the treatment of migraine headaches

A magnetic coil system for the treatment of foot pain which has an electrical pulse generator sequentially connected to three separate magnetic coils that have been placed around that patient's foot. The magnetic coil system consisting of one bottom coil, one coil on top of the foot and a third coil that is situated around the back of the foot and the bottom of the ankle. The three coils being separately and sequentially activated by the electrical pulse generator. The treatment of plantar fasciitis being accomplished by the activation of a series of intense magnetic pulsations using only the bottom coil.

Three-coil magnetic pulsations system for the treatment of foot pain

Growing community of inventors

Dayton, MD, United States of America

Robert E Fischell